Many studies suggest that RNA editing at the S/G site of AZIN1 is increased in multiple cancers, such as hepatocellular carcinoma, esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer (55, 59, 65, 66). Here, AZIN1 is linked to hepatocellular carcinoma.